MedStudy Facts Flashcards

1
Q

what PFT is obstructive

A

FEV1/FVC < 70 (actual)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what PFT seperates emphysema and chronic bronchitis

A

DLCO low - emphysema

DLCO preserved and bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what PFT is restriction

A

TLC low (<80% predicted)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what PFT seperates intrinsci and extrinsction

A

NMD, scoliosis, and obesity

DLCO intrinsic low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

isolated DLCO low

A

pulmonary arterial hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

flow volume loop obstructive

A

shortened loop and left shifted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

flow volume loop restrictive

A

skinny loop shifted to the right

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

fixed obstruction flow volume loop

A

flat up and bottom, tracheal stenosis or goiter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Extrathraocic inpiratory

A

flattening of the bottom part of the curve - vocal cord dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

extrathoracic expiratory loop

A

flattening of the top - tracheomalacia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

positive broncho change

A

> 12% change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

positive challenge test change

A

> 20 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IgE monoclonal antibody

A

omalizumab (need to have high IgE level) - monitor symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IL-5 monocolonal antibody

A

severe periphral eosinophilia (mepolizumab - Shingrex before), benralizumab, reslizumab (IV infusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dupilumab

A

IL-4/IL-13 (self injection), directly affect the smooth muscle as well as einosphils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

blood test for Churg-strauss

A

p-anca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

medical therapy COPD FEV1 50-80

A

long-actcing bronchov (titropium) (LABA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

medical therapy COPD FEV1 30-50

A

inhaled glucocorticoids

19
Q

careful with buproprion

A

lowers seizure threshold

20
Q

oxygen therapy

A

resting PaO2 < 55 or 88% or O2 sat < 89 if evidence of cor pulmonale

21
Q

apical disease (heterogenous)

A

lung volume reduction therapy

22
Q

roflimast

A

reduced exacerbation (chronic bronchitis)

23
Q

mortality reduction acute severe COPD

A

BIPAP

24
Q

RSBI

A

predicts weaning failure
< 105 is good
(RR/TV in L)

25
Q

FEV1 cut off for lung reduction

A

< 20

26
Q

light’s criteria

A

pleural/serum protein > 0.5
pleural/serum LDH > 0.6
pleural fluid LDH > 2/3 ULN LDH

27
Q

in setting of diuretic use, how to ensure not CHF on pleural effusion

A

serum-effusion difference > 3.1

28
Q

optimal peak airway pressure

A

<35

29
Q

optimal plateau airway pressure

A

< 30

30
Q

increase peak pressure with normal platau

A

mucous plug

31
Q

glucose goal in the ICU

A

140-180

32
Q

`initial ideal TV

A

8-10 mL/kg of ideal body weight

33
Q

location of endotrachel tube

A

2-6 cm above carina

34
Q

low O2 on ABG after intubaion

A

raise PEEP

35
Q

pCO2 high on ABG during mechancial vent

A

increase RR and increase TV

36
Q

ARDS TV

A

4-6 ml/kg

37
Q

ARDS tV

A

5-15

38
Q

flourscopic sniff test

A

diaphragm paralysis

39
Q

depth of ET insertion

A

20-23

40
Q

classic trial of fat embolism

A

confusion, hypoxemia, and petichial rash

41
Q

oxygen during flights

A

if SpO2 on ground is < 92

42
Q

classic triad of asperigosis

A

cough, pleurtic chest pain and hemoptysis

43
Q

CT chest of asperilogisis

A

nodules with ground glass or cavitation with air fluid levels

44
Q

tx asperilogisosi

A

voricanozole